Steven A. Schultz is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Sep 2023: RheoTek Medical LLC (New York, NY — biotechnology — 2023; $1.08M reported sold to 15 investors).
What this means One deal on file with the SEC, filed Sep 2023. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daniel Mazzaferro (1 shared filing) and Scott Bartlett (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Steven. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Steven A. Schultz and found 5 differences, 1 worth asking the sponsor about: Steven A. Schultz is no longer listed on the Sep 6, 2024 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.